Now showing items 1-7 of 7

    • Echiburú López, Bárbara; Pérez Bravo, Francisco; Maliqueo Yevilao, Manuel; Ladrón de Guevara, Amanda; Gálvez, Carla; Crisosto King, Nicolás; Sir Petermann, Teresa (2012)
      Background: The polycystic ovary syndrome (PCOS) is a hyperandrogenic disorder that arise from a combination of genetic and environmental factors. Aim: To assess the role of the androgen receptor (AR) CAG repeat polymorphism ...
    • Ladrón de Guevara, Amanda; Crisosto King, Nicolás; Echiburú López, Bárbara; Preisler, Jessica; Vantman, Natalie; Bollmann, Josefina; Pérez Bravo, Francisco; Sir Petermann, Lidia (Elsevier Ireland Ltd., 2013)
      Objective: To assess gonadotrophin secretion, ovarian steroid production and ovarian reserve in PCOS women during the onset of reproductive decline, in order to characterize their ovarian function at this age. Study ...
    • Crisosto King, Nicolás; Ladrón de Guevara, Amanda; Echiburú López, Bárbara; Maliqueo Yevilao, Manuel; Cavada, Gabriel; Codner Dujovne, Ethel; Paez, Francisco; Sir Petermann, Teresa (Elsevier Inc., 2019)
      © 2018 American Society for Reproductive MedicineObjective: To study the reproductive and metabolic differences between daughters of women with polycystic ovary syndrome (PCOSd) and control women (Cd) after menarche. Design: ...
    • Crisosto King, Nicolás; Echiburú López, Bárbara; Maliqueo Yevilao, Manuel; Pérez, Virginia; Ladrón de Guevara, Amanda; Preisler, Jessica; Sánchez, Fernando; Sir Petermann, Lidia (Elsevier, 2012-01)
      Objective: To evaluate the ovarian function during early infancy in daughters of women with polycystic ovary syndrome (PCOS) treated with metformin throughout pregnancy (PCOSdþM), as a means to reduce androgen and insulin ...
    • Echiburú López, Bárbara; Crisosto King, Nicolás; Maliqueo Yevilao, Manuel; Pérez Bravo, Francisco; Ladrón de Guevara, Amanda; Hernández, Paola; Cavada Chacón, Gabriel; Rivas, Catalina; Clavel, Andrés; Sir Petermann, Teresa (Elsevier, 2016)
      Objective. To assess insulin sensitivity, insulin secretion and metabolic profile in women with polycystic ovary syndrome (PCOS) in different stages of reproductive life. Materials and methods. In a cross-sectional ...
    • Ladrón de Guevara, Amanda; Vantman L., Nataly; Echiburú López, Bárbara; Miranda S., Daniel; Sir Petermann, Lidia (Sociedad Chilena de Endocrinología y Diabetes, 2013)
      Polycystic ovary syndrome is recognized as a risk factor for the development of type 2 diabetes and metabolic syndrome. The prevalence of the condition is 6 to 10% in different populations. Its etiology is not well known ...
    • Sir Petermann, Lidia; Ladrón de Guevara, Amanda; Codner Dujovne, Ethel; Preisler, Jessica; Crisosto King, Nicolás; Echiburú López, Bárbara; Maliqueo Yevilao, Manuel; Sánchez, Fernando; Pérez Bravo, Francisco; Cassorla Goluboff, Fernando (Society for Gynecologic Investigation, 2012-02-16)
      We have previously described increased serumlevels of anti-Mu¨llerian hormone (AMH) and stimulated insulin in daughters ofwomenwith polycystic ovary syndrome(PCOS), suggesting that these girlsmay have an altered ovarian ...